Heart Condition Speech

With medical and technological advancements, infant and child mortality rates have decreased over the years, but congenital heart disease is still a leading contributor to these mortality rates. Children with congenital heart disease undergo more severe and rapid medical treatment putting their parents through even harder times. These issues are worth exploring because congenital heart disease is an ongoing illness that has more and more relevant research being done on it. In the United States of America, an increasing number of children are being born and diagnosed with congenital heart disease (CHD) due to medical advancements. This illness not only impacts the infant’s life long term, but it also affects the parent’s well-being (Tak, & McCubbin, 2002). It has

Situation: Two patients in their 70s present to the office at different times today, each with documented heart failure: one diastolic and the other systolic, and both are hypertensive. First, discuss the difference between systolic and diastolic heart failure, providing appropriate pathophysiology. ACEI/ARBs are the only medications prescribed for CHF that have been found to prolong life and improve the quality of that life. EXPLAIN the mechanism of action of ACEI/ARBs and how they affect morbidity and mortality in CHF. Be specific. Diuretics must be used very carefully in diastolic ventricular dysfunction. EXPLAIN this statement using appropriate physiology. Now considering all of the above, describe an appropriate comprehensive plan of

Hello, Sheeneeka Freeman, I have had the pleasure of working with you in other classes here before. I look forward to working with you again this class. I hope we can both get a lot out of this course. If you don’t mind, I would like to hear more about how it is to be a Medical office specialist. I wish you luck on becoming a great medical assistant.

Heart failure affects nearly 6 million Americans. It is the leading cause of hospitalization in people older than 65. Roughly 550,000 people are diagnosed with heart failure each year (Emory Healthcare, 2014). Heart failure is a pathologic state where the heart cannot pump enough blood to meet the demand of the body’s metabolic needs or when the ventricle’s ability to fill is impaired. It is not a disease, but rather a complex clinical syndrome. The symptoms of heart failure come from pulmonary vascular congestion and inadequate perfusion of the systemic circulation. Individuals experience orthopnea,

Step 1: The Medication Prescription drugs are used to help people with health issues or problems that are occurring in their body. Insulin is used for people with Diabetes, and is prescribed by a doctor to control blood sugar in people with type 1 and 2 diabetes. Step 2: The Condition Most diseases have general symptoms that occur that notify you that you might have the disease. Diabetes mellitus is a chronic disease where people have too much sugar in the blood.

Ventricular Tachycardia. It is strange to think that somebody 21 years old could get such a complicated sounding disease. Initially I felt confused and a bit doubtful. I asked the doctor over and over again to make sure it was the correct diagnosis. Eventually I came to accept the fact that I have Ventricular Tachycardia. Eventually, I was able to see that having this disease didn’t have to be such a negative thing; that it could help me on my path. I went back to volunteering and shadowing with a new understanding. I was finally able to feel what the patients were going through, because I had gone through something similar. The confusion, fear, doubt, anger. I finally felt like I had the capacity to show empathy and understanding to patients and that medical school would help me to advance this ability

I was born and raised in Johannesburg, South Africa I immigrate to U.S.A. in 1996 with my son Nathan and a year later I got married to Teresa we have 2 kids TJ and Angeli who both are in college.

She was born with Tricuspid Atresia, Vetricula Steptum Defect, along with a Mirtral valve defect and numerous other medical issues. Tricuspid Atresia is a complex heart defect that occurs when the right ventricle in the heart fails to develop correctly during development in the womb. In Smilie’s case, it caused her to have little to no function in the right ventricle of the heart. To save Smilie’s life, doctors at the Prince Charles Hospital preformed a 3-stage surgery over 2 years to redirect blood flow within her body. Smilie had the BT Shunt at a few days old, the Hemi Fontan at 6 months old and the Fenestrated Fontan completed at 2 years of age. Smilie now has Hyploplastic Right Heart Syndrome as a result, which is a generalised term used to encompass the many conditions that can cause a lack of development in the Right Ventricle Side of the heart.

The definition of TOF reads, a type of congenital heart defect. Congenital means that it is present at birth (UMMC, 2013). TOF occurs when there is 4 abnormalities all together. One of the 4 abnormalities is when a massive hole is in the wall of the muscle (septum) that separates the 2 bottom pumping cambers (ventricles) of the heart. The massive hole in the abnormality itself is a VSD. A VSD is known as a Ventricular Septal Defect. Due to the location of the VSD, two more abnormalities develop. One being that there is a vast blood vessel which take the blood to the body (aorta) is pulled toward, and “overrides” the ventricular septum so that it sits over both the left and right ventricles; this is called an overriding aorta (UMMC, 2013). The second abnormality that takes place is that the muscle produces obstruction to the blood flow going out the right across the pulmonary valve. The right ventricular outflow tract obstruction, can be due to obstruction below the valve, at the valve or in the pulmonary arteries as they deliver blood out to the lungs (UMMC, 2013). There is different severities of TOF. The most acute form is known as pulmonary atresia. In patients with pulmonary atresia there is no functional pulmonary valve. The right ventricular outflow obstruction leads to thickening of the

Did you know that heart abnormalities are the most common birth defect? I didn't, until a few weeks ago. A Facebook friend posted a link to the Cora's Story blog and I casually clicked over to see what it was about. Cora died suddenly in her mama's arms at just 5 days old from an undetected congenital heart defect (CHD). I can't imagine suffering such a devastating loss, and I thank my lucky stars for my kids' healthy hearts. But Cora's mother Kristine has turned her pain into a wonderful mission in her daughter's name: to raise awareness about CHD and how easily it can be detected. With Kristine and Cora's help, hopefully more CHDs will be caught and treated early, saving babies' and children's lives.

A little girl by the name of Jaelyn was born with congenital heart disease (CHD). Jaelyn’s parents learned about her condition called Ebstein’s Anomaly during a fetal echocardiogram when her mother was only 30 weeks pregnant. The doctors and nurses at Cardinal Glennon Children’s Hospital monitored Jaelyn in-utero to watch for hydrops (heart failure) and other indications her heart disease was affecting her growth. Jaelyn went into heart failure just five weeks later when her mother was only 35 weeks pregnant. She was given a 5% chance of survival due to the severity of her defect. The family was also told Jaelyn would not survive past her first birthday; she turns five in March. When Jaelyn was born, her entire family was afraid she wouldn’t survive the delivery, but thankfully, Jaelyn’s story is a true miracle. When the doctors see Jaelyn during routine checkups and physician visits, they can’t believe she has Ebstein’s Anomaly because for how far she has come and how healthy she looks. Sadly, not every child with congenital heart disease gets the miracle Jaelyn has been given. Congenital heart disease has many causes that impact the child and

Congenital heart defects have become more prevalence in infants in the United States. The causes of congenital heart defects in infants are unknown. However, several factors have been linked to prenatal factors such as maternal insulin-dependent diabetes, maternal alcoholism, maternal rubella during pregnancy, and maternal age over forty. Many infants have been diagnosed with congenital heart defects in utero and the first week of life. Congenital heart defects have been detected in utero with the use of ultrasound in obstetric care. Other congenital heart defects have been diagnosed during the first week of life with symptoms in infants such as failure to thrive, failure to grow, feeding intolerance, hypoxia, signs and symptoms of congestive heart failure. The objectives of this paper are to present overviews of the congenital heart defects and outline the surgical treatments for the congenital heart defects.

Proper embryological development of the heart is crucial to proper functioning of the heart as an adult. The developing heart of a fetus follows several steps to ensure that the heart that develops has two way flow from atrium to ventricles to pulmonary or systemic circulation. While the steps in heart development are normally well controlled in a developing fetus, defects can arise and cause substantial problems postnatally. Specifically, when the embryological origin of the portioning between the left and right atria fails to develop normally, atrial septal defects can arise. Fortunately, there are surgicial options to prevent this defect and prevent interatrial mixing of oxygenated blood from the left atria with deoxygenated blood in the

A coronary calcium scan is an imaging test used to look for deposits of calcium and other fatty materials (plaques) in the inner lining of the blood vessels of the heart (coronary arteries). These deposits of calcium and plaques can partly clog and narrow the coronary arteries without producing any symptoms or warning signs. This puts a person at risk for a heart attack. This test can detect these deposits before symptoms develop.

Congenital heart diseases (CHDs) are the most prevalent of all birth defects and the leading cause of death in the first year of life, (1) with an annual prevalence ranging from six to twelve affected infants per 1,000 live births. (2)